Samuel Friedman

2.3k total citations · 1 hit paper
45 papers, 1.7k citations indexed

About

Samuel Friedman is a scholar working on Psychiatry and Mental health, Pharmacology and Pathology and Forensic Medicine. According to data from OpenAlex, Samuel Friedman has authored 45 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Psychiatry and Mental health, 7 papers in Pharmacology and 7 papers in Pathology and Forensic Medicine. Recurrent topics in Samuel Friedman's work include Attention Deficit Hyperactivity Disorder (6 papers), Treatment of Major Depression (6 papers) and Mental Health and Psychiatry (6 papers). Samuel Friedman is often cited by papers focused on Attention Deficit Hyperactivity Disorder (6 papers), Treatment of Major Depression (6 papers) and Mental Health and Psychiatry (6 papers). Samuel Friedman collaborates with scholars based in France, United States and United Kingdom. Samuel Friedman's co-authors include Jane E. Oltman, Stanley Zucker, Rita M. Lysik, E.S. Canellakis, John J. McGarry, Marcel Hayat, Patrice Carde, D Sarrazin, Thierry Le Chevalier and M. Spielmann and has published in prestigious journals such as New England Journal of Medicine, JAMA and Journal of Clinical Investigation.

In The Last Decade

Samuel Friedman

43 papers receiving 1.5k citations

Hit Papers

Depression: Clinical, Experimental, and Theoretical Aspects 1968 2026 1987 2006 1968 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Samuel Friedman France 15 635 396 263 257 160 45 1.7k
Michael Lewin United Kingdom 23 378 0.6× 385 1.0× 147 0.6× 177 0.7× 177 1.1× 88 1.6k
Stanley Lesse United States 16 281 0.4× 142 0.4× 242 0.9× 196 0.8× 170 1.1× 78 1.0k
et al United States 18 450 0.7× 289 0.7× 280 1.1× 420 1.6× 259 1.6× 75 1.8k
R.W. Trijsburg Netherlands 21 545 0.9× 281 0.7× 248 0.9× 658 2.6× 99 0.6× 38 2.2k
B. Peterson United States 16 329 0.5× 133 0.3× 251 1.0× 526 2.0× 105 0.7× 31 1.8k
James R. Stabenau United States 21 429 0.7× 162 0.4× 111 0.4× 380 1.5× 136 0.8× 47 1.4k
Jules J. Keyzer Netherlands 15 589 0.9× 718 1.8× 407 1.5× 105 0.4× 51 0.3× 27 2.3k
Richard E. Hicks Australia 19 477 0.8× 262 0.7× 325 1.2× 192 0.7× 142 0.9× 101 1.6k
Ellen Sullivan Mitchell United States 38 311 0.5× 268 0.7× 182 0.7× 217 0.8× 101 0.6× 78 4.0k
Masaru Horikoshi Japan 20 452 0.7× 374 0.9× 173 0.7× 122 0.5× 150 0.9× 88 1.5k

Countries citing papers authored by Samuel Friedman

Since Specialization
Citations

This map shows the geographic impact of Samuel Friedman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samuel Friedman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samuel Friedman more than expected).

Fields of papers citing papers by Samuel Friedman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samuel Friedman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samuel Friedman. The network helps show where Samuel Friedman may publish in the future.

Co-authorship network of co-authors of Samuel Friedman

This figure shows the co-authorship network connecting the top 25 collaborators of Samuel Friedman. A scholar is included among the top collaborators of Samuel Friedman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samuel Friedman. Samuel Friedman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Friedman, Samuel, M. Henry‐Amar, Jean‐Marc Cosset, et al.. (1991). Therapeutic implications and sites of relapse predicted by elevated posttherapy erythrocyte sedimentation rate in early stage Hodgkin disease. American Journal of Hematology. 37(4). 253–257. 5 indexed citations
2.
Henry‐Amar, M., Samuel Friedman, Marcel Hayat, et al.. (1991). Erythrocyte Sedimentation Rate Predicts Early Relapse and Survival in Early-Stage Hodgkin Disease. Annals of Internal Medicine. 114(5). 361–365. 67 indexed citations
3.
4.
Flamant, F, Annie Rey, J M Caillaud, et al.. (1989). Rhabdomyosarcoma in infants under one year of age: Experience of the institut Gustave‐Roussy. Medical and Pediatric Oncology. 17(5-6). 424–428. 14 indexed citations
6.
Henry‐Amar, M., Bernard Caillou, Samuel Friedman, et al.. (1988). Lymphoblastic lymphoma in adults: a clinicopathological study of 34 cases treated at the Institut Gustave-Roussy. European Journal of Cancer and Clinical Oncology. 24(10). 1609–1616. 11 indexed citations
7.
Zucker, Stanley, Samuel Friedman, & Rita M. Lysik. (1974). Bone Marrow Erythropoiesis in the Anemia of Infection, Inflammation, and Malignancy. Journal of Clinical Investigation. 53(4). 1132–1138. 95 indexed citations
8.
Friedman, Samuel, et al.. (1972). Ornithine decarboxylase activity in synchronously growing Don C cells. Biochimica et Biophysica Acta (BBA) - General Subjects. 261(1). 188–193. 46 indexed citations
9.
Friedman, Samuel. (1969). The Schizophrenic Syndrome. JAMA. 210(6). 1105–1105. 71 indexed citations
10.
Friedman, Samuel. (1968). Depression: Clinical, Experimental, and Theoretical Aspects. JAMA. 203(13). 1144–1144. 898 indexed citations breakdown →
11.
Friedman, Samuel. (1968). The Psychiatric Consultation. JAMA. 205(4). 253–253. 20 indexed citations
12.
Oltman, Jane E. & Samuel Friedman. (1966). Perphenazine-Amitriptyline in the Treatment of Schizophrenia. American Journal of Psychiatry. 123(5). 607–609. 8 indexed citations
13.
Oltman, Jane E. & Samuel Friedman. (1965). PROTRIPTYLINE IN THE TREATMENT OF DEPRESSIVE REACTIONS. American Journal of Psychiatry. 122(5). 582–584. 3 indexed citations
14.
Oltman, Jane E. & Samuel Friedman. (1963). EVALUATION OF NORTRIPTYLINE IN THE TREATMENT OF AFFECTIVE DISORDERS (AND COMPARISON WITH OTHER DRUGS). American Journal of Psychiatry. 119(10). 988–989. 11 indexed citations
15.
Oltman, Jane E. & Samuel Friedman. (1962). COMPARISON OF TEMPORAL FACTORS IN DEPRESSIVE PSYCHOSES TREATED BY EST AND ANTIDEPRESSANT DRUGS. American Journal of Psychiatry. 119(6). 579–580. 2 indexed citations
16.
Oltman, Jane E. & Samuel Friedman. (1962). LIFE CYCLES IN PATIENTS WITH MANIC-DEPRESSIVE PSYCHOSIS. American Journal of Psychiatry. 119(2). 174–176. 4 indexed citations
17.
Oltman, Jane E. & Samuel Friedman. (1961). LONG-TERM RESULTS OF FRONTAL LOBOTOMY IN SCHIZOPHRENIC PATIENTS. American Journal of Psychiatry. 118(1). 70–71. 1 indexed citations
18.
Friedman, Samuel & Paul L. Munson. (1959). Concentration of parathyroid hormone activity by chromatography on carboxymethylcellulose. Biochimica et Biophysica Acta. 35. 509–515. 1 indexed citations
19.
Friedman, Samuel & Paul L. Munson. (1958). Preliminary fractionation of parathyroid extract with ammonium sulfate. Biochimica et Biophysica Acta. 28(1). 204–205. 4 indexed citations
20.
Oltman, Jane E., et al.. (1951). THE ELECTROCARDIOGRAM IN PSYCHIATRIC PATIENTS. The Journal of Nervous and Mental Disease. 113(1). 127–135. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026